Related references
Note: Only part of the references are listed.Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid
Sahar Semaan et al.
EUROPEAN RADIOLOGY (2020)
Magnetic Resonance Imaging With Extracellular Contrast Detects Hepatocellular Carcinoma With Greater Accuracy Than With Gadoxetic Acid or Computed Tomography
Ji Hye Min et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS
Dong Ik Cha et al.
EUROPEAN RADIOLOGY (2020)
Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging
Sunyoung Lee et al.
HEPATOLOGY INTERNATIONAL (2020)
Comparison of extracellular and hepatobiliary MR contrast agents for the diagnosis of small HCCs
Anita Paisant et al.
JOURNAL OF HEPATOLOGY (2020)
Diagnostic performance of MRI for HCC according to contrast agent type: a systematic review and meta-analysis
Dong Wook Kim et al.
HEPATOLOGY INTERNATIONAL (2020)
Pitfalls and problems to be solved in the diagnostic CT/MRI Liver Imaging Reporting and Data System (LI-RADS)
Yeun-Yoon Kim et al.
EUROPEAN RADIOLOGY (2019)
Retrospective validation of a new diagnostic criterion for hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout with the aid of ancillary features?
Ijin Joo et al.
EUROPEAN RADIOLOGY (2019)
Validation of Liver Imaging Reporting and Data System 2017 (LI-RADS) Criteria for Imaging Diagnosis of Hepatocellular Carcinoma
Andrea S. Kierans et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2019)
Prospective evaluation of gadoxetic acid magnetic resonance for the diagnosis of hepatocellular carcinoma in newly detected nodules ≤2 cm in cirrhosis
Carmen Ayuso et al.
LIVER INTERNATIONAL (2019)
Hepatocellular Carcinoma
Augusto Villanueva
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH-HCC guidelines) 2019 update
Norihiro Kokudo et al.
HEPATOLOGY RESEARCH (2019)
Gadoxetic Acid-enhanced MRI of Hepatocellular Carcinoma: Value of Washout in Transitional and Hepatobiliary Phases
Dong Hwan Kim et al.
RADIOLOGY (2019)
2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Joong-Won Park et al.
KOREAN JOURNAL OF RADIOLOGY (2019)
Comparison of international guidelines for noninvasive diagnosis of hepatocellular carcinoma: 2018 update
Tae-Hyung Kim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis
Lewis R. Roberts et al.
HEPATOLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System
Ji Hye Min et al.
HEPATOLOGY (2018)
Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients
Victoria Chernyak et al.
RADIOLOGY (2018)
Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017)
Ying Ding et al.
CANCER IMAGING (2018)
Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2017)
Gadoxetic acid disodium-enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: A meta-analysis
Xijiao Liu et al.
LIVER TRANSPLANTATION (2017)
2017 Version of LI-RADS for CT and MR Imaging: An Update
Khaled M. Elsayes et al.
RADIOGRAPHICS (2017)
Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background
Norihide Yoneda et al.
RADIOGRAPHICS (2016)
Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout?
Ijin Joo et al.
EUROPEAN RADIOLOGY (2015)
Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol
Julian A. Luetkens et al.
EUROPEAN RADIOLOGY (2015)
Evaluation of Early-Stage Hepatocellular Carcinoma by Magnetic Resonance Imaging With Gadoxetic Acid Detects Additional Lesions and Increases Overall Survival
Hyung-Don Kim et al.
GASTROENTEROLOGY (2015)
Hepatocellular Carcinoma: Diagnostic Performance of Multidetector CT and MR Imaging-A Systematic Review and Meta-Analysis
Yoon Jin Lee et al.
RADIOLOGY (2015)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤2 cm) HCC in cirrhosis
Rita Golfieri et al.
EUROPEAN RADIOLOGY (2011)
Detection of Small Hepatocellular Carcinoma Intraindividual Comparison of Gadoxetic Acid-Enhanced MRI at 3.0 and 1.5 T
Young Kon Kim et al.
INVESTIGATIVE RADIOLOGY (2011)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths
M Rohrer et al.
INVESTIGATIVE RADIOLOGY (2005)
Share Paper
